PerClot to Control Bleeding in Endoscopic Sinus Surgery

CryoLife Europa12 enrolled

Overview

A prospective, single centre, single arm study designed to collect clinical data on PerClot when used in subjects undergoing endoscopic sinus surgery.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Sinusitis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects having Endoscopic Sinus Surgery * Subjects who will have PerClot used as a haemostatic agent * Subjects willing and able to give consent * Subjects over 18 years old Exclusion Criteria: * Subjects unable or unwilling to give consent for their data to be collected

Locations (1)

Guys and St Thomas NHS Trust

London, United Kingdom

Outcomes

Primary Outcomes

Number of subjects who achieve of haemostasis after the application of PerClot

Time frame: intraoperatively

Secondary Outcomes

Number of subjects who require the use of alternative methods to achieve haemostasis after the application of PerClot

Time frame: intraoperatively

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.